University Health Network
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uhn.ca
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Not yet recruiting
- Conditions
- Extubation
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 3000
- Registration Number
- NCT06442930
- Locations
- π¨π¦
University Health Network, Toronto, Ontario, Canada
The Semaglutide Study
Recruiting
- Conditions
- Fasting
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 100
- Registration Number
- NCT06420739
- Locations
- π¨π¦
Toronto Western Hospital, Toronto, Ontario, Canada
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
Phase 2
Recruiting
- Conditions
- Advanced CancerStage IV MelanomaEndocrine CancerStage IV Solid Tumor CancerStage IV Sarcoma of BoneStage IV Lymphoma
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 15
- Registration Number
- NCT06416085
- Locations
- π¨π¦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
ALTERNATE DAY ULTRAHYPOFRACTIONATED OR DAILY MODERATELY HYPOFRACTIONATED POST OPERATIVE RADIOTHERAPY (AMPORA)
Phase 2
Recruiting
- Conditions
- Post-Operative Prostate Cancer
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2024-05-10
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 204
- Registration Number
- NCT06409910
- Locations
- π¨π¦
University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN)
Phase 1
Recruiting
- Conditions
- Chemotherapy-induced Peripheral Neuropathy
- Interventions
- Behavioral: EX-CIPN
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 40
- Registration Number
- NCT06405542
- Locations
- π¨π¦
ELLICSR: Health Wellness and Cancer Survivorship Centre, Toronto, Ontario, Canada
Albumin Utilization in Adult Cardiac Surgical Patients : A Multicentre Prospective Cohort Study
Recruiting
- Conditions
- Antithrombin III LevelsAlbumin Levels
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 100
- Registration Number
- NCT06395480
- Locations
- π¨π¦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
π¨π¦Toronto General Hospital - University Health Network, Toronto, Ontario, Canada
EASE-SOT Pilot Study
Not Applicable
Not yet recruiting
- Conditions
- Transplant;Failure,KidneyTransplant; Failure, HeartTransplant; Failure, PancreasTransplant; Failure, LiverTransplant; Failure, Lung(S)
- Interventions
- Other: EASE-SOT
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 120
- Registration Number
- NCT06396702
- Locations
- π¨π¦
Toronto General Hospital, Toronto, Ontario, Canada
Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation
Phase 4
Not yet recruiting
- Conditions
- Distal Radius Fractures
- Interventions
- Drug: Topical TRanexamic AcidDrug: Placebo
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 90
- Registration Number
- NCT06384456
- Locations
- π¨π¦
Toronto Western Hospital, Toronto, Ontario, Canada
Belimumab in Autoimmune Hepatitis
Phase 2
Recruiting
- Conditions
- Autoimmune Hepatitis
- Interventions
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 48
- Registration Number
- NCT06381453
- Locations
- π¨π¦
Toronto General Hospital, Toronto, Ontario, Canada
Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction
Phase 1
Completed
- Conditions
- Post COVID-19 Condition
- Interventions
- Device: Hi-OxSR Sequential Rebreathing mask (oxygen concentrator)
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 37
- Registration Number
- NCT06379620
- Locations
- π¨π¦
University Health Network, Toronto, Ontario, Canada
Β© Copyright 2025. All Rights Reserved by MedPath